ONCOREX INC has a total of 22 patent applications. Its first patent ever was published in 2003. It filed its patents most often in Japan, WIPO (World Intellectual Property Organization) and Canada. Its main competitors in its focus markets pharmaceuticals, biotechnology and measurement are CONNECTIVE THERAPEUTICS INC, AEGERION PHARMACEUTICALS INC and INSIGHT BIOPHARMACEUTICALS LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | Japan | 5 | |
#2 | WIPO (World Intellectual Property Organization) | 5 | |
#3 | Canada | 4 | |
#4 | China | 4 | |
#5 | EPO (European Patent Office) | 3 | |
#6 | Australia | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Measurement | |
#4 | Organic fine chemistry |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Medical preparations | |
#3 | Peptides | |
#4 | Microorganisms | |
#5 | Measuring microorganism processes | |
#6 | Analysing materials | |
#7 | Heterocyclic compounds |
# | Name | Total Patents |
---|---|---|
#1 | Kobayashi Masanobu | 14 |
#2 | Masanobu Kobayashi | 3 |
#3 | Jian Chen | 3 |
#4 | Chen Jian | 2 |
#5 | Shinobu Wakako | 2 |
#6 | Okuzawa Ami | 2 |
#7 | Koide Hideyuki | 2 |
#8 | Takanori Hitoshi | 2 |
#9 | Shao Jun | 2 |
#10 | Shinobu Noriaki | 1 |
Publication | Filing date | Title |
---|---|---|
JP2008106040A | PPARgamma ACTIVATOR | |
JP2008285438A | PPARgamma ACTIVATOR | |
WO2007114449A1 | Low-glucose-inducible or low-glucose-and-hypoxia-inducible genes, proteins, and uses thereof | |
JP2007084494A | Pim-1 activity inhibitor | |
JP2007082422A | Dendritic cell having migration capability even under low oxygen condition and utilization of the same | |
JP2008000003A | Pim-1 ACTIVITY/PROTEIN INHIBITING PHARMACEUTICAL | |
CA2477867A1 | Peptides, dna's, rna's, and compounds for inhibiting or inducing adrenomedullin activity, and use of the same | |
CA2521169A1 | Pharmaceutical agents | |
WO2005004926A1 | Dendritic cell infiltrativity activating composition and immune activator | |
CN101090715A | Dendritic cell infiltrativity activating composition and immune activator | |
CN1753909A | Peptides and pharmaceutical compositions comprising said peptides and medical composition for treating cancer |